Seres Therapeutics (MCRB) vs Shuttle Pharmaceuticals (SHPH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Shuttle Pharmaceuticals is the larger company by market cap ($26.4 million vs $26.4 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | MCRB | SHPH |
|---|---|---|
| Share price | $2.63 | $5.55 |
| Market cap | $26.42M | $26.44M |
| 1-day change | -3.31% | +17.83% |
| YTD return | — | -69.17% |
| 1-year return | — | -87.36% |
| EPS (TTM) | $-2.42 | $-16.87 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $29.98 | $55.90 |
| 52-week low | $2.42 | $2.58 |
| Distance from 52-week high | -91.23% | -90.07% |
| Average volume | 72.00K | 1.36M |
| Shares outstanding | 10.04M | 4.76M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
MCRB vs SHPH FAQ
Which is bigger, Seres Therapeutics or Shuttle Pharmaceuticals?
Shuttle Pharmaceuticals (SHPH) is larger, with a market capitalization of $26.44M compared with $26.42M for Seres Therapeutics (MCRB).
Are Seres Therapeutics and Shuttle Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.